Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fedorova
Alexandra Fedorova, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20110246995 | CACHE-AWARE THREAD SCHEDULING IN MULTI-THREADED SYSTEMS - The disclosed embodiments provide a system that facilitates scheduling threads in a multi-threaded processor with multiple processor cores. During operation, the system executes a first thread in a processor core that is associated with a shared cache. During this execution, the system measures one or more metrics to characterize the first thread. Then, the system uses the characterization of the first thread and a characterization for a second, second thread to predict a performance impact that would occur if the second thread were to simultaneously execute in a second processor core that is also associated with the cache. If the predicted performance impact indicates that executing the second thread on the second processor core will improve performance for the multi-threaded processor, the system executes the second thread on the second processor core. | 10-06-2011 |
Elena Fedorova, Whippany, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100159045 | COSMETIC USE OF ACTIVE AGENTS FOR STIMULATING THE EXPRESSION OF FN3K AND/OR FN3K RP TO IMPROVE THE SKIN'S BARRIER FUNCTION - A cosmetic process for caring for human skin, intended for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function is also disclosed. | 06-24-2010 |
| 20100184867 | USE OF ACTIVE AGENTS FOR STIMULATING THE EXPRESSION OF FN3K AND/OR FN3K RP FOR COMBATING AGEING OF THE SKIN - A cosmetic process for caring for human skin, which is intended for preventing and/or combating at least one sign of ageing of the skin or the ‘orange peel’ appearance of the skin, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing and/or combating at least one sign of ageing of the skin or the ‘orange peel’ appearance of the skin associated with cellulite is also disclosed. | 07-22-2010 |
Julia G. Fedorova, Nizhny Novgorod RU
| Patent application number | Description | Published |
|---|---|---|
| 20090103769 | COGNITIVE CONTROL FRAMEWORK FOR AUTOMATIC CONTROL OF APPLICATION PROGRAMS EXPOSURE A GRAPHICAL USER INTERFACE - The present invention relates generally to automatic control of software application programs and image analysis and, more specifically, to analyzing graphical component, an execution scenario script, and a playback component. The recording component is adapted to capture user input data and images displayed by the graphical user interface during a recording phase of execution of the application program, and to analyze the captured user input data and displayed images to generate an execution scenario (script) during the recording phase. The execution scenario may be written in a selected high level language (e.g., XML). The playback component is adapted to generate simulated user input data based on the execution scenario during a playback phase of execution of the application program, to input the simulated user input data to the application program, to perform image analysis on images displayed by the graphical user interface as a result of processing the simulated user input data during the playback phase and captured displayed images from the recording phase; and to automatically control execution of the application program based at least in part on the image analysis. | 04-23-2009 |
Lyudmyla Mykolaivna Fedorova, Kiev UA
| Patent application number | Description | Published |
|---|---|---|
| 20090182118 | METHOD FOR PRODUCING POLYGUANIDINES - The invention relates to polyguanidine synthesis. The inventive method for producing polyguanidines consists in polycondensing a guanidine salt with diamine during heating in the presence of an organic acid or a mixture of organic acids. A heating process is carried out stepped process and consists in gradually increasing a temperature up to 120-130° C. and in holding at said temperature for 0.5-1.0 hour, in increasing a temperature up to 150-160° C. and in holding at said temperature for 3.5-4.0 hours and in increasing a temperature up to 170-180° C. and in holding at said temperature for 1.0-1.5 hours. Said method makes it possible obtain, in a more full manner and in shorter time, a polyguanidine, which exhibits a high biological activity. The thus obtained polyguanidines are not toxic and can be efficiently used for treating drinking and sewage waters and for producing antiseptic, cosmetic and disinfecting agents. | 07-16-2009 |
Marina Leonidovna Fedorova, G.krasnodar RU
| Patent application number | Description | Published |
|---|---|---|
| 20090071874 | METHOD OF ISOMERIZATION OF LIGHT GASOLINE FRACTIONS - The invention relates to isomerization of light gasoline fractions to produce a high octane gasoline component, and may be used in oil refining and petrochemical industries. | 03-19-2009 |
Nataliya V. Fedorova, Kiev UA
| Patent application number | Description | Published |
|---|---|---|
| 20090017708 | LIGHTWEIGHT HIGH-TENSILE, HIGH-TEAR STRENGTH BIOCOMPONENT NONWOVEN FABRICS - A method of producing a nonwoven fabric comprising spinning a set of bicomponent fibers which include an external fiber component and an internal fiber component. The external fiber enwraps said internal fiber and has a higher elongation to break value than the internal fiber and a lower melting temperature than the internal fiber component. The set of bicomponent fibers are positioned onto a web and thermally bonded to produce a nonwoven fabric. | 01-15-2009 |
Nataliya V. Fedorova US
| Patent application number | Description | Published |
|---|---|---|
| 20110250812 | HIGH STRENGTH, DURABLE MICRO & NANO-FIBER FABRICS PRODUCED BY FIBRILLATING BICOMPONENT ISLANDS IN THE SEA FIBERS - The subject matter disclosed herein relates generally to fabrics composed of micro-denier fibers wherein said fibers are formed as bicomponent fibrillated fiber. The energy is sufficient for fibrillating as well as entangling (bonding) the fibers. These fabrics can be woven or knitted and made from made from bicomponent islands in the sea fibers and filaments or can be nonwovens and formed by either spunbonding or through the use of bicomponent staple fibers formed into a web by any one of several means and bonded similarly to those used for the spunbonded filament webs. | 10-13-2011 |
Nataliya V. Fedorova, Raleigh, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110318986 | MICRO AND NANOFIBER NONWOVEN SPUNBONDED FABRIC - The invention provides methods for the preparation of nonwoven spunbonded fabrics and various materials prepared using such spunbonded fabrics. The method generally comprises extruding multicomponent fibers having an islands in the sea configuration such that upon removal of the sea component, the island components remain as micro- and nanofibers. The method further comprises mechanically entangling the multicomponent fibers to provide a nonwoven spunbonded fabric exhibiting superior strength and durability without the need for thermal bonding. | 12-29-2011 |
Olga V. Fedorova, Lutherville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100158900 | ANTI-MARINOBUFAGENIN ANTIBODIES AND METHODS FOR THEIR USE - Described herein are deposited hybridoma cell lines and the monoclonal antibodies produced by these hybridomas, and antigen binding fragments thereof. These monoclonal antibodies and antigen binding fragments specifically bind marinobufagenin. The disclosure also encompasses the use of these monoclonal antibodies or antigen binding fragments in a method for detecting the presence of marinobufagenin in a biological sample. Also provided are methods for the use of these monoclonal antibodies or antigen binding fragments as prophylactic, therapeutic, and diagnostic agents for the detection, inhibition and treatment of a cardiovascular disease, for example, essential hypertension, hypertension associated with preeclampsia, eclampsia, or renal failure, or myocardial fibrosis in a subject. | 06-24-2010 |